A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis

NCT07663331 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Non-infectious Uveitis

Interventions

DRUG: TyboWe® Adalimumab Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.